Literature DB >> 11835679

Delayed chromosome changes in gamma-irradiated normal and Li-Fraumeni fibroblasts.

J M Boyle1, A R Spreadborough, M J Greaves, J M Birch, J M Varley, D Scott.   

Abstract

Knockout mice with only one Trp53 allele (+/- genotype) are highly susceptible to radiation-induced cancers, possibly through numerical chromosome changes. Patients with the Li-Fraumeni syndrome, having heterozygous TP53 germline mutations (+/mut genotype), are also susceptible to spontaneous and radiogenic cancers. We have investigated the susceptibility of six Li-Fraumeni syndrome +/mut and six normal fibroblast strains to induced numerical and unstable structural aberrations at six population doublings after exposure to 3 or 6 Gy gamma rays. Four of the irradiated Li-Fraumeni syndrome strains showed small increases in both aberration types, similar to those seen in the normal strains. In two irradiated Li-Fraumeni syndrome strains, there were high levels of induced structural changes, and one of these showed a modest increase in hyperploidy. We suggest that enhanced sensitivity to delayed radiation-induced chromosome changes in Li-Fraumeni syndrome cells requires other genetic alterations in addition to TP53 heterozygosity, apparently in contrast to the situation in Trp53 heterozygous null mice. If such additional alterations occur in vivo in Li-Fraumeni syndrome patients, they may predispose them to radiogenic cancers, mainly through enhanced structural rather than numerical chromosome changes. Our findings raise questions about the validity of quantitative extrapolation of cytogenetic data from Trp53-defective mice to radiogenic cancer risk in humans.

Entities:  

Mesh:

Year:  2002        PMID: 11835679     DOI: 10.1667/0033-7587(2002)157[0158:dccigi]2.0.co;2

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  6 in total

Review 1.  Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes.

Authors:  D G R Evans; J M Birch; R T Ramsden; S Sharif; M E Baser
Journal:  J Med Genet       Date:  2005-09-09       Impact factor: 6.318

Review 2.  Early occurrence of lung adenocarcinoma and breast cancer after radiotherapy of a chest wall sarcoma in a patient with a de novo germline mutation in TP53.

Authors:  Alessandra Ferrarini; Agnes Auteri-Kaczmarek; Alessia Pica; Nemya Boesch; Karl Heinimann; Stephan C Schäfer; Sara Vesnaver-Megalo; Viviane Cina; Jacques S Beckmann; Christian Monnerat
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

Review 3.  Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature.

Authors:  Karin Kast; Mechthild Krause; Markus Schuler; Katrin Friedrich; Barbara Thamm; Andrea Bier; Wolfgang Distler; Stefan Krüger
Journal:  BMC Cancer       Date:  2012-06-06       Impact factor: 4.430

4.  Limited importance of the dominant-negative effect of TP53 missense mutations.

Authors:  Ewelina Stoczynska-Fidelus; Malgorzata Szybka; Sylwester Piaskowski; Michal Bienkowski; Krystyna Hulas-Bigoszewska; Mateusz Banaszczyk; Izabela Zawlik; Dorota Jesionek-Kupnicka; Radzislaw Kordek; Pawel P Liberski; Piotr Rieske
Journal:  BMC Cancer       Date:  2011-06-13       Impact factor: 4.430

5.  (18)F-FDG PET-CT for Surveillance of Brazilian Patients with Li-Fraumeni Syndrome.

Authors:  Sonia Tereza Santos Nogueira; Eduardo Nóbrega Pereira Lima; Amanda França Nóbrega; Ivone Do Carmo Gonçalves Torres; Marcelo Cavicchioli; Pierre Hainaut; Maria Isabel Waddington Achatz
Journal:  Front Oncol       Date:  2015-02-19       Impact factor: 6.244

6.  Allelic losses in mouse skin tumors induced by gamma-irradiation of p53 heterozygotes.

Authors:  Tomonori Miyazawa; Hiroki Sato; Katsuyoshi Hatakeyama; Tomoyuki Kitagawa; Ryo Kominami
Journal:  Jpn J Cancer Res       Date:  2002-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.